Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
7 No-Brainer Biotech Stocks to Add to Your Buy List
09:58am, Thursday, 09'th Jun 2022
With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile. The post 7 No-Brainer Biotech Stocks to Add to Your Buy List appeared first
Why Is CRISPR Therapeutics AG (CRSP) Up 45.9% Since Last Earnings Report?
03:30pm, Wednesday, 08'th Jun 2022 Zacks Investment Research
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is CRISPR Therapeutics AG (CRSP) Up 45.9% Since Last Earnings Report?
12:48pm, Wednesday, 08'th Jun 2022
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock?
2 Top Biotech Stocks to Buy in June
10:00am, Wednesday, 08'th Jun 2022 The Motley Fool
Potential catalysts lie ahead for both of these biotech companies.
CRISPR Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
08:00am, Wednesday, 08'th Jun 2022
ZUG, Switzerland and CAMBRIDGE, Mass., June 08, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ser
7 Oversold Stocks to Buy Right Now
07:00am, Wednesday, 08'th Jun 2022
Identifying oversold stocks gives investors the opportunity to buy shares that they perhaps already liked, only at a discounted price. The post 7 Oversold Stocks to Buy Right Now appeared first on Inv
2 Green Flags for Vertex Pharmaceuticals' Future
02:00pm, Friday, 03'rd Jun 2022 The Motley Fool
Investors have plenty to look for with this leading biotech.
Have $2,000? 2 Market Crash-Ready Stocks to Buy
10:00am, Sunday, 22'nd May 2022 The Motley Fool
These stocks have great long-term prospects.
Vertex (VRTX) Outperforms Industry This Year So Far: Here's Why
01:06pm, Wednesday, 18'th May 2022 Zacks Investment Research
Vertex's (VRTX) cystic franchise sales continue to grow. Vertex has a broad clinical non-CF pipeline, which is progressing rapidly.
Analyst Ratings for CRISPR Therapeutics
04:03pm, Tuesday, 17'th May 2022 Benzinga
Over the past 3 months, 11 analysts have published their opinion on CRISPR Therapeutics (NASDAQ:CRSP) stock. These analysts are typically employed by large Wall Street banks and tasked with understand
Caribou Charges Ahead on Study Results
03:07pm, Tuesday, 17'th May 2022
Shares of Caribou Biosciences Inc. ( CRBU , Financial) are up more than 46% since last Thursday, leading the way for several beaten-down biotechs that also rose after investors got a look at the prese
CRISPR (CRSP) Focuses on Pipeline Amid Lack of Marketed Drugs
06:23pm, Monday, 16'th May 2022 Zacks Investment Research
While CRISPR Therapeutics' (CRSP) lead candidate is still a couple of years away from commercialization, it is highly dependent on collaboration revenues to fund its ongoing pipeline.
CRISPR (CRSP) Focuses on Pipeline Amid Lack of Marketed Drugs
03:48pm, Monday, 16'th May 2022
While CRISPR Therapeutics' (CRSP) lead candidate is still a couple of years away from commercialization, it is highly dependent on collaboration revenues to fund its ongoing pipeline.
Here's the No. 1 Reason to Buy Vertex Pharmaceuticals Now
10:30am, Saturday, 14'th May 2022 The Motley Fool
The company's current treatments dominate the cystic fibrosis market, but it's the pipeline that makes this stock so intriguing.
Why Editas Medicine's Shares Fell 28.9% This Week
03:52pm, Friday, 13'th May 2022 The Motley Fool
The company's progress for its lead therapy has been slow.
